Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.
Karina L. Berenson, MPH
Advertisement
Articles by Karina L. Berenson, MPH
Advertisement
Latest Updated Articles
- Cost-Offset Analysis: Bimatoprost Versus Other Prostaglandin Analogues in Open-Angle Glaucoma
Published: September 8th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
3
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
4
Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits
5